Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

Thorax10.00
Volume: 72, Issue: 4, Pages: 340 - 346
Published: Apr 1, 2017
Abstract
Rationale There is no consensus as to when treatment for idiopathic pulmonary fibrosis (IPF) should be initiated. Some physicians prefer not to treat patients with preserved lung volume. Objective To investigate whether patients with IPF and preserved lung volume receive the same benefit from nintedanib as patients with more impaired lung volume. Methods Post hoc subgroup analyses of pooled data from the two replicate phase III INPULSIS trials...
Paper Details
Title
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Published Date
Apr 1, 2017
Journal
Volume
72
Issue
4
Pages
340 - 346
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.